We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PHARMACEUTICAL RESOURCES TO BUY KALI LABORATORIES
PHARMACEUTICAL RESOURCES TO BUY KALI LABORATORIES
April 13, 2004
Pharmaceutical Resources (PRX), the parent company of generic drugmaker Par Phramaceutical, yesterday said it would acquire generic firm Kali Laboratories for $135 million – a move that more than doubles PRX’s research and development capabilities.